Table 4.

Ten vaccine–event pairs for which model 3 gave the highest probability of being an adverse reaction following immunization

Vaccine: event	Listed?	PRRE	PRRLL	KSBE	KSBV	Prob model 1 (%)	Prob model 2 (%)	Prob model 3 (%)
Engerix™: Myalgia	Yes	]0.8, 1.2]	]0.8, 1.2]	[Min, Q1[	0	36	84	93
Infanrix™: Pyrexia	Yes	[0, 0.8]	[0, 0.8]	[Min, Q1[	0	9	84	86
Rotarix™: Diarrhoea	Yes	]10, 100]	]10, 100]	[Min, Q1[	[Min, Q1[	16	86	84
Engerix™: Pruritus	Yes	]0.8, 1.2]	]0.8, 1.2]	0	[Min, Q1[	36	69	83
Engerix™: Vomiting	Yes	]0.8, 1.2]	]0.8, 1.2]	[Min, Q1[	[Q1, Median[	36	70	83
Engerix™: Abdominal pain	Yes	]1.2, 2]	]0.8, 1.2]	[Q1, Median[	[Min, Q1[	24	74	82
Twinrix™: Fatigue	Yes	]0.8, 1.2]	]0.8, 1.2]	>0.01	[Min, Q1[	36	67	82
Engerix™: Arthralgia	Yes	]0.8, 1.2]	]0.8, 1.2]	0	0	36	65	82
Havrix™: Headache	Yes	]0.8, 1.2]	[0, 0.8]	[Median, Q3[	0	12	77	81
Cervarix™: Pyrexia	Yes	]0.8, 1.2]	[0, 0.8]	[Median, Q3[	0	12	77	81

BE between events, BV between vaccines, E estimate, KS Kolmogorov–Smirnov, LL lower limit, Prob estimated probability, PRR proportional reporting ratio